Results 141 to 150 of about 7,548 (263)

IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy [PDF]

, 2015

core   +1 more source

Cost-Effectiveness of Once-Weekly Insulin Icodec versus Daily Basal Insulins in Chinese Adults with T2DM: A Treatment-Background Stratified Analysis

ClinicoEconomics and Outcomes Research
Zeyu Xie,1 Weishang Deng,2 Zhuoru Liang,1 Yilin Xie,1 Jisheng Chen,3 Weiling Cao1 1Department of Pharmacy, The Third Affiliated Hospital (The Affiliated Luohu Hospital) of Shenzhen University, Shenzhen, Guangdong Province, People’s Republic of China ...
Xie Z, Deng W, Liang Z, Xie Y, Chen J, Cao W   +5 more
doaj  

Model for Simulating Fasting Glucose in Type 2 Diabetes and the Effect of Adherence to Treatment. [PDF]

, 2017
Aradóttir, Tinna Björk, Bengtsson, Henrik, Boiroux, Dimitri, Jørgensen, John Bagterp, Kildegaard, Jonas, Orden, Brad V.   +5 more
core   +1 more source

Effect of Beta-Cell Function on Glucose Variability When Switching From Insulin Degludec Plus a Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide: Preliminary Results From a Pilot Study. [PDF]

Int J Endocrinol
Oe Y, Nomoto H, Nakamura A, Kuwabara S, Takahashi Y, Yasui A, Izumihara R, Miya A, Kameda H, Cho KY, Atsumi T.   +10 more
europepmc   +1 more source

A Novel Insulin Combination of Insulin Degludec and Insulin Aspart Achieves a More Stable Overnight Glucose Profile Than Insulin Glargine: Results from Continuous Glucose Monitoring in a Proof-of-Concept Trial [PDF]

, 2013
Andreas Liebl, Jaime A. Davidson, Henriette Mersebach, Patrik Dykiel, Cees J. Tack, Tim Heise   +5 more
openalex   +1 more source

Efficacy and safety of insulin degludec/insulin aspart biosimilar B01711 vs originator insulin degludec/insulin aspart in Chinese patients with type 2 diabetes inadequately controlled on basal or premixed insulin: A multicenter, randomized, open-label, phase 3 study. [PDF]

J Diabetes Investig
Gao L, Cheng Z, Ma G, Cai X, Wang X, Lu Y, Li Z, Li W, Zhao S, Li X, Song C, Gao Y, Geng J, Cao H, Sun J, Ji L.   +15 more
europepmc   +1 more source

Utilizing ELISA-plate based immunopurification and liquid chromatography-tandem mass spectrometry for the urinary detection of short- and long acting human insulin analogues [PDF]

, 2018
Deventer, Koen, Judák, Péter, Van Eenoo, Peter   +2 more
core   +2 more sources

Safety and Clinical Outcomes of Insulin Degludec in Korean Patients with Diabetes in Real-World Practices: A Prospective, Observational Study. [PDF]

Diabetes Ther, 2023
Lee BW, Ahn KJ, Cho HC, Lee EY, Min K, Dahaoui A, Jeong JS, Lim HJ, Jang HC.   +8 more
europepmc   +1 more source

Review for "Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomised, controlled, open‐label, cross‐over trial"

, 2021

openalex   +1 more source

Early insulin degludec with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial. [PDF]

Diabetes Obes Metab
Thammakosol K, Jantarapootirat M, Traiwanatham S, Sriphrapradang C.   +3 more
europepmc   +1 more source